Cargando…
纳米药物联合CAR-T疗法在实体肿瘤治疗中的研究进展
Chimeric antigen receptor T cell (CAR-T) therapy has shown remarkable success in treating hematological malignancies. However, CAR-T therapy for solid tumors is still limited due to the unique solid-tumor microenvironment and heterogeneous target antigen expression, which leads to an urgent need of...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987048/ https://www.ncbi.nlm.nih.gov/pubmed/36792082 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.102.02 |